ReviewSubstance abuse and rehabilitation2026
Recent Trends in Cannabis Use in Adults Ages 60 Years and Older.
Review in Substance abuse and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This narrative review highlights the growing population of older adults (OA) who use cannabis and health considerations of cannabis use especially relevant to aging. The majority of OA who endorse using cannabis also report choosing it for medical purposes, most commonly to target symptoms of pain, insomnia, anxiety, and depression. However, many OA who use cannabis also do not discuss their use with their medical providers, and additional controlled clinical trials are needed to delineate which symptoms cannabis can successfully alleviate and any conditions or circumstances for which it is contraindicated. Further, emerging research in younger populations has documented possible cardiovascular risks of heavy cannabis use, and this area has yet to be thoroughly investigated in aging adults despite risk for vascular and other forms of dementia. Preclinical models are beginning to offer insight into health effects of cannabis use with aging, including cognition and dementia risk. In particular, cannabis represents a possible treatment for cognitive decline and neurodegeneration in OA, but further research is needed to characterize effects of cannabis use in healthy aging versus dementia processes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.